These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 25625874)
21. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams. Gemmel M; Rayen I; van Donkelaar E; Loftus T; Steinbusch HW; Kokras N; Dalla C; Pawluski JL Neuroscience; 2016 Jul; 327():32-43. PubMed ID: 27060483 [TBL] [Abstract][Full Text] [Related]
22. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment. Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180 [TBL] [Abstract][Full Text] [Related]
23. The neuropharmacology of serotonin and noradrenaline in depression. Nutt DJ Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606 [TBL] [Abstract][Full Text] [Related]
24. Duloxetine pharmacology: profile of a dual monoamine modulator. Karpa KD; Cavanaugh JE; Lakoski JM CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192 [TBL] [Abstract][Full Text] [Related]
29. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Butler SG; Meegan MJ Curr Med Chem; 2008; 15(17):1737-61. PubMed ID: 18673223 [TBL] [Abstract][Full Text] [Related]
30. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder. Khandker RK; Kruzikas DT; McLaughlin TP J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572 [TBL] [Abstract][Full Text] [Related]
32. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior. Soiza-Reilly M; Meye FJ; Olusakin J; Telley L; Petit E; Chen X; Mameli M; Jabaudon D; Sze JY; Gaspar P Mol Psychiatry; 2019 May; 24(5):726-745. PubMed ID: 30279456 [TBL] [Abstract][Full Text] [Related]
33. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus. Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120 [TBL] [Abstract][Full Text] [Related]
34. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats. Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228 [TBL] [Abstract][Full Text] [Related]
35. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression. Kanekar S; Ettaro R; Hoffman MD; Ombach HJ; Brown J; Lynch C; Sheth CS; Renshaw PF Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360959 [TBL] [Abstract][Full Text] [Related]
36. [Serotonin and antidepressant treatments: new issues about the therapeutic mechanism of action]. Lista Varela A Vertex; 2003; 14(51):25-9. PubMed ID: 12690406 [TBL] [Abstract][Full Text] [Related]
37. [Domino principle--monoamines in bottom-view]. Sümegi A Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617 [TBL] [Abstract][Full Text] [Related]
38. Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. Romero L; Bel N; Casanovas JM; Artigas F Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():1-8. PubMed ID: 8923121 [TBL] [Abstract][Full Text] [Related]
39. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202 [TBL] [Abstract][Full Text] [Related]
40. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. Frazer A J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]